Chongqing Peg-bio Biopharm Co., Ltd.

This early-stage study is testing the safety and side effects of a single injection called PN20 in adults with chronic immune thrombocytopenia (ITP), a condition where the body attacks its own platelets. The main goal is to see if PN20 is safe for these patients and if it might h…

This study is testing a single injection called PN20 to see if it can safely raise platelet counts in adults with chronic liver disease who need a planned medical procedure. Low platelet counts (thrombocytopenia) are common in liver disease and can increase bleeding risk during p…

This study is testing whether a new injectable drug called PJ009 can help people with short bowel syndrome reduce their need for intravenous (IV) nutrition. Researchers will compare PJ009 to a placebo in about 72 patients aged 14 and older over 36 weeks. The main goal is to see i…